Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2010
11/04/2010US20100278791 Adeno-associated virus serotype i nucleic acid sequences, vectors and host cells containing same
11/04/2010US20100278790 Mesenchymal stem cells, compositions, and methods for treatment of cardiac tissue damage
11/04/2010US20100278789 Methods of generating expanded and re-differentiated adult islet beta cells capable of producing insulin
11/04/2010US20100278788 Osteogenic Differentiation Of Bone Marrow Stem Cells And Mesenchymal Stem Cells Using A Combination Of Growth Factors
11/04/2010US20100278787 Cardiomyocyte-like cell clusters derived from hbs cells
11/04/2010US20100278786 Use of the opposite cell differentiation program (ocdp) for the treatment of degenerated organs in the pathological state
11/04/2010US20100278785 Injection device for injection into biological tissue and injection depot
11/04/2010US20100278783 Method of Preparing Autologous Cells and Method of Use for Therapy
11/04/2010US20100278782 Differentiation of rat liver epithelial cells into hepatocyte-like cells
11/04/2010US20100278775 Plant Bioreactor For The Production Of Interleukin-24 Cytokine
11/04/2010US20100278774 Fusion molecules and il-15 variants
11/04/2010US20100278768 Compounds and Methods for Inhibiting Axillary Malodour
11/04/2010US20100278729 Breast cancer eradication program
11/04/2010US20100278724 Inhibition of migration and induction of cell death by the type ii collagen amino propeptides
11/04/2010DE102010018878A1 New cell line stably expressing both beta-adrenergic receptor and a cyclic adenosine monophosphate sensor, useful for diagnosing beta-adrenergic receptor-mediated disease including e.g. infectious and non-infectious heart diseases
11/04/2010CA2760642A1 Anti-cadherin antibody
11/04/2010CA2760608A1 Method of expanding human hepatocytes in vivo
11/04/2010CA2760482A1 Method for production of anti-tumor trail protein
11/04/2010CA2760042A1 Compositions and methods for modulating stem cells and uses thereof
11/04/2010CA2759978A1 Method for obtaining human microglial precursor cells from pluripotent stem cells
11/04/2010CA2759968A1 Microglial precursor cells for the treatment of malignant neoplasms of the central nervous system
11/04/2010CA2759911A1 Protein electron mediator
11/03/2010EP2246430A1 Anti-adam-15 antibodies and utilization of the same
11/03/2010EP2246426A1 Composition for neutralizing botulinus toxin type-a, and human anti-botulinus toxin type-a antibody
11/03/2010EP2246424A1 Novel hydrogen peroxide-forming nadh oxidase, and dna encoding the same
11/03/2010EP2246418A1 Lignan hydroxylase
11/03/2010EP2246417A1 Recombinantly modified plasmin
11/03/2010EP2246416A1 Mutated Abl kinase domains
11/03/2010EP2246414A1 Cell culture method and screening method
11/03/2010EP2246363A1 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis
11/03/2010EP2245156A1 Humanized anti- 9 integrin antibodies and the uses thereof
11/03/2010EP2245150A1 Protease for wound conditioning and skin care
11/03/2010EP2245143A2 Thermophilic and thermoacidophilic metabolism genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods
11/03/2010EP2245142A2 Identification of cd8+ t cells that are cd161hi and/or il18r(alpha)hi and have rapid drug efflux capacity
11/03/2010EP2245141A1 Stem cell aggregates and methods for making and using
11/03/2010EP2245140A2 Compositions comprising hdac inhibitors and methods of their use in restoring stem cell function and preventing heart failure
11/03/2010EP2245139A1 Reconstructed cornea and mucous membrane
11/03/2010EP2245059A1 Cd4+ t-cells with cytolytic properties
11/03/2010EP2244715A1 Methods for gene transfer to mammals
11/03/2010EP1712626B1 Unsaturated fatty acid synthase gene originating in marchantiales plant and utilization of the same
11/03/2010EP1499742B1 Nad(p)h oxidase inhibitors for increased glucose uptake and treatment of type ii diabetes
11/03/2010EP1268760B1 Recombinant proteins containing shiga-like toxin and vascular endothelial growth factor fragments
11/03/2010EP1076662B1 Polyepitope carrier protein
11/03/2010EP0912734B1 Chimeric heteromultimer adhesins
11/03/2010EP0568575B2 Test and model for alzheimer's disease
11/03/2010CN1774502B Process for producing cartilage cells for transplantation
11/03/2010CN1244215B Improved method for the production and purification of adenoviral vectors
11/03/2010CN101878302A Pseudomonas aeruginosa outer membrane protein PA4710
11/03/2010CN101878301A Antibody and use thereof
11/03/2010CN101878298A Differentiation of human embryonic stem cells
11/03/2010CN101878297A Methods and compositions for optimized expansion and implantation of mesenchymal stem cells
11/03/2010CN101878296A Methods of reducing intracellular fats from mammalian cells
11/03/2010CN101878295A Improved methods of producing RPE cells and compositions of RPE cells
11/03/2010CN101878034A Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
11/03/2010CN101875957A Chinese hamster apoptosis-related genes
11/03/2010CN101875946A Anti-influenza virus medicament screening model and application thereof
11/03/2010CN101875940A Salt-tolerant sinorhizobium meliloti NSM18 and special gene cluster thereof
11/03/2010CN101875934A Promoter BgIosP546, preparation method thereof and use thereof
11/03/2010CN101875916A FGFR1 high-expression recombinant HEK293 cell and application thereof
11/03/2010CN101875700A Method for improving bioactivity of exendin fusion protein
11/03/2010CN101875699A Fusion protein of human epidermal growth factor and metallothionein and preparation method and application thereof
11/03/2010CN101875697A Design of novel anti-EGFR humanized antibody TGM10 and application thereof
11/03/2010CN101875696A Antibody, and preparation method and application thereof
11/03/2010CN101875695A Antibody, and coding gene and application thereof
11/03/2010CN101875692A Chinese hamster apoptosis-related genes
11/03/2010CN101875689A New gene for rice zinc-finger protein transcription factor and application thereof to drought resistance and salt tolerance
11/03/2010CN101874473A Method for inducing maize microspore to form embryoid
11/03/2010CN101555479B Moss expressing promoting regions
11/03/2010CN101519649B Hybridoma strain and preparation method thereof
11/03/2010CN101305693B High irrigation blueberry cultured shoots one-step seedling establishment method
11/03/2010CN101100674B BIV infectivity indication cell line using firefly luciferase as reporting gene
11/02/2010US7825310 Maize variety PHWEJ
11/02/2010US7825309 Maize variety 36H43
11/02/2010US7825308 Maize variety 32D78
11/02/2010US7825305 Tobacco having increased threonine
11/02/2010US7825299 Soybean variety XB18U09
11/02/2010US7825298 Soybean cultivar S06-03DL75132
11/02/2010US7825295 Method and means for modulating plant cell cycle proteins and their use in plant cell growth control
11/02/2010US7825229 MiRNAs; diagnosis, prognosis, and treatments; drug screening; linear amplification and labeling for hybridization techniques like Luminex and Microarray analysis; gene expression inhibition
11/02/2010US7825228 Bone mineralization proteins, DNA, vectors, expression systems
11/02/2010US7825225 Vaccine
11/02/2010US7825098 promoting brown adipocyte differentiation by contacting a preadipocyte or a white adipocyte with a small interfering RNA (siRNA) that binds specifically to an mRNA encoding Necdin, wherein the siRNA selectively inhibits Necdin expression in an amount sufficient to increase Uncoupling Protein-1 expression
11/02/2010US7825094 the sensitivity of cells typical of various proliferative disorders to the ansamycin CNF-101 ("17-AAG") is proportional to the HER-2 levels in those cells
11/02/2010US7824914 Flavonoids-rich tissues from Neomarica gracilis and methods for culturing the same
11/02/2010US7824913 Tissue engineering; in vitro method for inducing cells to produce an extracellular matrix; living extracellular matrix, which has tissue-like properties, can be used for testing or clinical purposes
11/02/2010US7824912 Methods for ex vivo propagation of adult hepatic stem cells
11/02/2010US7824911 Hepatic stellate cell progenitors and methods of isolating same
11/02/2010US7824910 Generating polyamine/polypeptide conjugate and transferring polypeptide into tissues; regeneration medicine; tissue engineering
11/02/2010US7824907 Expression vectors comprising the mCMV IE2 promoter
11/02/2010US7824897 comprising N-{3-(hydroxyaminocarbonyl)-1-oxo-(2R)-benzylpropyl}-Ile-Leu-OH as in catalytic domain of modified tumor necrosis factor-alpha converting enzyme; less susceptible to autoproteolysis; drug design
11/02/2010US7824895 Phytases, nucleic acids encoding them and methods for making and using them
11/02/2010US7824894 Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof
11/02/2010US7824869 Apoproteins; membrane proteins; high throughput screening
11/02/2010US7824850 Methods of protein destabilization and uses thereof
11/02/2010US7824849 determining whether a target cell expresses telomerase reverse transcriptase (TRT) by combining human T lymphocytes ex vivo with antigen-presenting cells containing a polypeptide that comprises at least 8 consecutive amino acids of telomerase reverse transcriptase
11/02/2010US7824847 Tissue preservation method with polyoxyethylene/polyoxypropylene copolymer
11/02/2010US7824711 comprising osteogenesis enhancing material selected from juvenile cartilage, neocartilage particles or mixtures and biocompatible matrices, used for bone maintenance and regeneration
11/02/2010US7824683 Methods for augmenting an immune response using anti-CD40 antibodies
11/02/2010US7824677 inhibiting blood coagulation mediated by factor X binding to tissue factor; provide superior anti-coagulant activity by binding native human tissue factor with high affinity and specificity; linked covalently to a cell antigen or an effector molecule to provide complement fixing ability
11/02/2010US7824671 Retinal pigment epithelial cell cultures on amniotic membrane and transplantation
1 ... 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 ... 1827